McKesson Corporation
McKesson Reports Strong Fiscal 2026 Results and Announces Share Repurchase Program
Summary
McKesson Corporation reported strong financial results for the fiscal year ended March 31, 2026, with consolidated revenues increasing by 12% to $403.4 billion and adjusted earnings per diluted share rising by 18% to $39.11. The company also announced a $2.25 billion accelerated share repurchase program and a $5.0 billion increase to its existing share repurchase authorization, bringing the total to $7.7 billion. Additionally, McKesson plans to separate its Medical-Surgical Solutions segment. The company provided fiscal 2027 adjusted earnings per diluted share guidance of $43.80 to $44.60, indicating 12% to 14% growth compared to the prior year.
Profitelligence Alerts
Get alerts for MCK
Be first to know when McKesson Corporation files with the SEC.
Filing Categories
Advertisement
About McKesson Corporation
McKesson Corporation is a leading healthcare services and information technology company. It plays a crucial role in the distribution of pharmaceuticals and medical products. The primary function of McKesson is to ensure the efficient delivery of healthcare products to pharmacies, hospitals, and other medical facilities, ensuring that millions of patients have access to the medications they need. It also provides specialized software and automated solutions that enhance operational efficiency in healthcare sectors. McKesson significantly impacts the pharmaceutical and healthcare industries by offering solutions that streamline supply chains and improve patient care. Its services encompass wholesale drug distribution, healthcare IT systems, and pharmacy management. With operations that extend globally, McKesson is integral to maintaining the integrity and reliability of healthcare supply networks. By handling a substantial portion of the pharmaceutical distribution in North America, McKesson Corporation has a vital market presence, emphasizing its importance in shaping healthcare logistics and innovation. Its efforts contribute to advancing healthcare delivery and responding to the evolving demands of the medical industry.
Official SEC Documents
Advertisement